This compound is a chiral pharmaceutical intermediate featuring a tetrahydrofuran ring substituted with a difluoromethoxyphenyl group and multiple fluorine atoms. Its stereochemistry is defined, making it suitable for use in the synthesis of enantiomerically pure active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2649470-87-9
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt
n.a
N-Carbobenzoxy-L-glutamine
protected amino acid intermediate
(2S)-1-methoxypropan-2-ol
Pharmaceutical intermediate for olmesartan medoxomil
3-amino-N-(4-aminophenyl)benzamide
pharmaceutical intermediate
Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-
Pharmaceutical intermediate for benzimidazolone synthesis
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
active pharmaceutical ingredient
Suzetrigine Impurity 4
Pharmaceutical impurity reference standard
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carboxylic acid
HMJBDIINGXHMMN-BEWJGFNTSA-N
C[C@H]1[C@H]([C@@H](O[C@@]1(C)C(F)(F)F)C(=O)O)C2=C(C(=C(C=C2)F)F)OC